Stay updated on Cabozantinib vs Everolimus in Metastatic Renal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib vs Everolimus in Metastatic Renal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib vs Everolimus in Metastatic Renal Cell Carcinoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A minor revision update was applied: Revision: v3.3.4 replacing v3.3.3. This metadata change does not affect the study details, eligibility criteria, endpoints, or user-facing content on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T02:40:24.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Expanded the study locations by adding numerous site locations across the US, Argentina, Australia, and Europe, broadening enrollment options. Removed the HHS Vulnerability Disclosure entry and several location groups.
    Difference
    4%
    Check dated 2025-12-23T21:57:39.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    Publications section description updated to note that entries are automatically filled from PubMed and may not be about the study. Revision label updated from v3.2.0 to v3.3.2.
    Difference
    0.0%
    Check dated 2025-11-25T11:53:22.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Removed the prominent notice stating that information on the site may not be up to date due to a lapse in government funding. The notice previously advised users to check cc.nih.gov and opm.gov for operating status updates.
    Difference
    0.1%
    Check dated 2025-11-18T07:19:51.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The changes appear to be cosmetic, involving layout adjustments on the Study Details page, with no changes to core content such as eligibility criteria, endpoints, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T21:18:50.000Z thumbnail image
  8. Check
    102 days ago
    Change Detected
    Summary
    Major update to page content: introduces a government funding/status notice and current operating status for NIH Clinical Center, and updates the version from v3.1.0 to v3.2.0.
    Difference
    2%
    Check dated 2025-10-06T05:54:10.000Z thumbnail image

Stay in the know with updates to Cabozantinib vs Everolimus in Metastatic Renal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib vs Everolimus in Metastatic Renal Cell Carcinoma Clinical Trial page.